Yahoo
HKSE - Delayed Quote HKD

TransThera Sciences (Nanjing), Inc. (2617.HK)

8.040 -0.045 (-0.56%)
At close: 4:08:03 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
Cash Flow from Operating Activities, Indirect
-251,127 -253,511 -271,182 -319,326
Cash Flow from Investing Activities
-313,236 -67,998 348,421 -186,938
Cash Flow from Financing Activities
548,726 168,995 -4,871 15,759
Cash and Cash Equivalents, End of Period
425,267 415,408 569,506 496,629
Cash Flow, Supplemental
Free Cash Flow to Firm
-244,859 -279,431 -263,237 -358,453
Capital Expenditure, Calculated
806 164 773 11,790
Issuance of Capital Stock
551,483 172,199 0 20,000
Repurchase of Capital Stock
-342 -525 -1,636 -734
12/31/2023 - 6/23/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: